Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
algorithm
andexanet
antiarrhythmic drugs
anticoagulant, complications of
anticoagulant, contraindications
anticoagulant, discontinuation
anticoagulant, restarting
anticoagulant, reversal of
anticoagulant, treatment
anticoagulant, treatment in CVD
anticoagulation effect
anticoagulation, perioperative
apixaban
argatroban
arrhythmia, cardiac
aspirin
asymptomatic
atrial appendage closure
atrial fibrillation
atrial fibrillation, nonvalvular
atrial fibrillation, risk stratification
atrial fibrillation, surgical treatment
atrial fibrillation, treatment
atrial flutter
atrial septal defect
bedridden
breast feeding
bridge therapy
bronchoscopy
cancer associated hypercoagulation
cancer, cerebrovascular accident complicating patients with
carcinoma
cardiomyopathy
carotid artery occlusion, intracranial
carotid artery occlusion, perioperative
CAT scan, abnormal
cataract surgery
cerebral embolism
cerebral embolism, cardiac origin
cerebral embolism, mechanical extraction
cerebral infarction
cerebral venous thrombosis
cerebrovascular accident
cerebrovascular accident, acute management of
cerebrovascular accident, cardiac disease causing
cerebrovascular accident, complications with
cerebrovascular accident, cryptogenic
cerebrovascular accident, postoperative
cerebrovascular accident, prevention of
cerebrovascular accident, primary prevention
cerebrovascular accident, recurrent
cerebrovascular accident, secondary prevention
cerebrovascular accident, severity
cerebrovascular accident, thrombolytic agents in treatment
cerebrovascular accident, women
cerebrovascular accident, young adult
CHADS-VaSC score
ciraparantag
clopidogrel
clot retrieval
colonoscopy
compliance
complications
controversies in neurology
cost
cost effectiveness
coumarin
coumarin, restarting treatment
coumarin, stopping treatment
cryoablation
dabigatran
dabigatran, dose
deafness, unilateral
delivery, complicated
dental procedure, neurologic complications with
dialysis
drug interactions
dural sinus thrombosis
dyspepsia
edoxaban
efficacy
electromyogram
embolic stroke of unknown source
embolism, systemic
endoscopic surgery
endoscopy
endovascular therapy
enoxaparin
evidence-based research
factor Xa inhibitor
falling
fibrinolytic agents
fibrinolytic agents, complications
fibrinolytic agents, contraindications
fibrinolytic agents, intra-arterial local infusion
fibrinolytic therapy, selection criteria
gastrointestinal bleeding
HAS-BLED score
head injury
headache
heart valve, prosthetic
hemorrhagic diathesis
hemostatic therapy
heparin
heparin, low-molecular-weight
heparinoid, low molecular weight
hepatic failure
hip arthroplasty
Holter monitoring
hormone replacement
hormone therapy
iatrogenic neurologic disorders
idarucizumab
incidental finding
INR value, time in range
INR values
intracerebral hemorrhage
intracerebral hemorrhage, progression of
intracerebral hemorrhage, silent
intracerebral hemorrhage, treatment of
intracerebral hemorrhage, volume
intracranial hemorrhage
labor, complicated
left atrial appendage, percutaneous closure
left ventricular dysfunction
liver disease
liver function enzymes
menopause
MERCI trial
microhemorrhage, intracerebral
middle cerebral artery, occlusion of
mimics
misdiagnosis
mortality
MRI, abnormal
myocardial infarction
neurologic complications of, surgery
neuroradiology, interventional
NIH stroke scale
non-vitamin K antagonist oral anticoagulants
non-vitamin K antagonist oral anticoagulants, coagulation test
number needed to treat
old age, neurology of
oral contraceptives
oral contraceptives, cerbrovascular disease and
ovarian induction
pacemaker, cardiac-transvenous
partial thromboplastin time
patent foramen ovale, surgical treatment of
patient information and support
peri-procedural
platelet inhibiting drugs
platelet inhibiting drugs, combined
platelet inhibiting drugs, discontinuation
postoperative neurologic complications
practice guidelines
pregnancy, neurologic complications in
prevention of neurologic disorders
prognosis
prothrombin complex concentrate
prothrombin time
prothrombin time, prolonged
radiofrequency ablation
rapid thromboelasticity
recanalization, arterial
recurrent
RELY trial
renal failure
reperfusion
RESPECT trial
review article
risk factors
risk factors, modification
risk stratification
risk-benefit assessment
rivaroxaban
ROCKET - AF trial
safety
serum alanine aminotransferase
solitaire device
SPORTIF trial
stent, carotid artery
subarachnoid hemorrhage
subarachnoid hemorrhage, cerebral convexity
subdural hematoma
T lesion of MCA-ICA
teratogenesis
teratogenic drugs
thrombectomy
thrombin inhibitor
thrombolysis, mechanical
thrombophlebitis
thrombus, mural
tissue plasminogen activator, intravenous
transient ischemic attack
transient neurologic deficit
transluminal angioplasty, coronary artery
transurethral prostatectomy
trauma
treatment of neurologic disorder
venous thrombosis, non-cerebral
vitamin K
vitamin K antagonist
Watchman device
ximelagatran
Showing articles 600 to 650 of 865 << Previous Next >>

N-Acetylcysteine Therapy for Unverricht-Lundborg Disease
Neurol 52:426-427, Selwa,L.M., 1999

Efficacy and Safety of Rivastigmine in Patients with Alzheimer's Disease:International Randomised Controlled
BMJ 318:633-640, 615, Rosler,M.,et al, 1999

Prevention of a First Stroke,A Review of Guidelines and a Multidisciplinary Consensus Statement from the National Stroke Association
JAMA 281:1112-1120,1146, Gorelick,P.B.,et al, 1999

Cost-Effectiveness of Donepezil in the Treatment of Mild or Moderate Alzheimer's Disease
Neurol 52:1138-1145,1115, Neumann,P,J.,et al, 1999

Relation of Consumption of Vitamin E, Vitamin C, and Carotenoids to Risk for Stroke among Men in the United States
Ann Int Med 130:963-970, Ascherio,A.,et al, 1999

Randomized Trial of Sildenafil for the Treatment of Erectile Dysfunction in Spinal Cord Injury
Ann Neurol 46:15-21, Giuliano,F.,et al, 1999

Effect of Aldose Reductase Inhibition on Nerve Conduction and Morphomedtry in Diabetic Neuropathy
Neurol 53:580-591, Greene,D.A.,et al, 1999

Neuroprotective Properties of Statins in Cerebral Ischemia and Stroke
Stroke 30:1969-1973, Vaughan,C.J.&Delanty,N., 1999

Clinical Benefits of Donepezil:Results from a Long-Term Phase III Extension Trial
Neurol 52:A174, Doody,R.S.,et al, 1999

Neostigmine for the Treatment of Acute Colonic Pseudo-Obstruction
NEJM 341:137-141, Ponec,R.J.,et al, 1999

Is Cholesterol a Risk Factor for Stroke? No
Arch Neurol 56:1521-1524, Landau,W.M., 1999

Is Cholesterol a Risk Factor for Stroke? Yes
Arch Neurol 56:1518-1520,1524, Demchuk,A.M.,et al, 1999

Treatment of Alzheimer's Disease
NEJM 341:1670-1679, Mayeux,R.&Sano,M, 1999

Effect of Vitamin C on Frequency of Reflex Sympathetic Dystrophty in Wrist Fractures:A Randomised Trial
Lancet 354:2025-2028, Zollinger,P.E.,et al, 1999

HAART Improves Prognosis in HIV-Associated Progressive Multifocal Leukoencephalopathy
Neurol 52:623-625,440, Clifford,D.B.,et al, 1999

Clinicopath Conf,Sarcoidosis,with Involvement of Spinal Cord,Brain,Mediastinal Lymph Nodes and ? Lung,Case 35-1998
NEJM 339:1534-1541, , 1998

The Role of Weight Loss and Acetazolamide in the Treatment of Idiopathic Intracranial Hypertension (Pseudotumor Cerebri)
Ophthalmology 105:2313-2317, Johnson,L.N.,et al, 1998

Dementia with Lewy Bodies:Response of Delirium-Like Features to Donepezil
Neurol 51:1512, Kaufer,D.I.,et al, 1998

Tasmar (tolcapone) Labeling Revisions of Package Insert
Roche Laboratories, , 1998

Serotonin Syndrome Induced by Transitioning from Phenelzine to Venlafaxine:four Patient Reports
Neurol 51:274-276, Diamond,S.,et al, 1998

Progressive Multifocal Leukoencephalopathy, HIV, and Highly Active Antiretroviral Therapy
NEJM 339:848-849, Cinque,P.,et al, 1998

Effect of Selegiline on Mortality in Patients with Parkinson's Disease
Neurol 51:825-830, Olanow,C.W.,et al, 1998

Anticoagulation Therapy in Pediatric Patients with Sinovenous Thrombosis,A Cohort Study
Arch Neurol 55:1533-1537, deVeber,G.,et al, 1998

Lipodystrophy Associated with an HIV-Protease Inhibitor
NEJM 339:1296, Carr,A.&Cooper,D.A., 1998

Buffalo Hump in a Patient with the Acquired Immunodeficiency Syndrome
NEJM 339:1297, Aboulafia,D.M.&Bundow,D., 1998

Efficacy and Safety of Oral Sildenafil (Viagra) in Men with Erectile Dysfunction Caused by Spinal Cord Injury
Neurol 51:1629-1633, Derry,F.A.,et al, 1998

Regress of HIV Enceph & Basal Ganglia Signal Intensity Abnor MRI in AIDS after Protease Inhibitor
Neuroradiology 206:491-498, Filippi,C.G.,et al, 1998

Morality in DATATOP:A Multicenter Trial in Early Parkinson's Disease
Parkinson Study Group, Ann Neurol 43:318-3251998., , 1998

Mortality in People Taking Selegiline:Observational Study
BMJ 317:252-254, Thorogood,M.,et al, 1998

Managing the Neuropsychiatric Symptoms of Parkinson's Disease
Neurol 50:S33-S38, Lieberman,A., 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Random, Placebo-Contr Study of Tolcapone in Pts with Fluctuating Parkinson Dis Trtd With Levodopa-Carbidopa
Arch Neurol 55:1089-1095, Adler,C.H.,et al, 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Effect of HMGcoA Reductase Inhibitors on Stroke, A Meta-Analysis of Controlled Trials
Ann Int Med 128:89-95, Bucher,H.C.,et al, 1998

Lovastatin for X-Linked Adrenoleukodystrophy
NEJM 339:702-703, Singh,I.,et al, 1998

Synergistic Immunomod Effects of Interferon-Beta1b & Phosphodiesterase Inhib Pentoxifylline in Pts with Relapsing-Remit MS
Ann Neurol 44:27-34, 71998., Weber,F.,et al, 1998

Pharmacologic Treatment of Cognition in Alzheimer's Dementia
Neurol 51:S36-S44, Farlow,M.R.&Evans,R.M., 1998

Donepezil Improves Cognition & Global Function in Alzheimer Dis, 15-Week Doub-Blind, Plac-Contr Study
Arch Int Med 158:1021-1031, 9411998., Rogers,S.L.,et al, 1998

Metrifonate Benefits Cognitive, Behvioral, and Global Function in Patients with Alzheimer's Disease
Neurol 50:1222-1230, 12031998., Morris,J.C.,et al, 1998

Metrifonate Treatment of the Cognitive Deficits of Alzheimer's Disease
Neurol 50:1214-1221, 12031998., Cummings,J.L.,et al, 1998

Spinal and Epidural Hematoma and Low-Molecular-Weight Heparin
NEJM 338:1774-1775, Wysowski,D.K.,et al, 1998

HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998

A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Pts with Alzheimer's Disease
Neurol 50:136-145, Rogers,S.,et al, 1998

Diagnosis and Treatment of Alzheimer Disease and Related Disorders
JAMA 278:1363-1371, Small,G.W.,et al, 1997

Epidural/Spinal Hematoma with Low Molecular Weight Heparin & Spinal/Epidural Anesth or Spinal Puncture
FDA Advisory, Dec 151997., , 1997

Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997

Vascular Effects of Statins in Stroke
Stroke 28:2315-2320, Delanty,N.&Vaughan,C.J., 1997

An Update on Primary Drug Therapies for Alzheimer Disease
Arch Neurol 54:1406-1409, Knopman,D.S.&Morris,J.C., 1997

Clinical Experience with Donepezil Hydrochloride:A Case Study Perspective
Advan Therapy 14:305-311, Geldmacher,D.S., 1997



Showing articles 600 to 650 of 865 << Previous Next >>